In the present study, we investigated the prognostic role of CDKN2A homozygous deletion in WHO grade 4 CNS gliomas, including IDH-mutant astrocytoma’s and IDH-wildtype glioblastomas. The gene discussed is IDH1; the disease is glioblastoma.